| Literature DB >> 16398334 |
E Kommisrud1, O Osterås, T Vatn.
Abstract
A survey of blood selenium (Se) concentrations in Norwegian Red heifers and dry period cows was conducted to reveal possible association to management, feeding, health and fertility. Selenium contents were determined in 254 herd blood samples consisting of pooled samples from individual non-lactating animals from herds in 5 counties. The Se concentrations showed a normal distribution with mean 0.09 microg Se/g blood, with a standard deviation (SD) of 0.05, and ranged from 0.02 to 0.23 microg/g, with 50 % of the samples being between 0.06 and 0.11 microg/g. The herds with Se concentrations below 0.06 microg/g were smaller (21.4 +/- 8.7 cow-years) than those with Se levels above 0.11 microg/g (27.5 +/- 14.1 cow-years) (P<0.01), but there were no differences in milk yield, incidence of replacement, proportion of animal culling, amount of concentrate or grass silage as percentage of energy consumption between the groups. Treatment registration records showed a tendency that more animals in the low Se herds were treated for all the diseases included in this investigation (64.8 animals per 100 cow-years) than those in the high Se herds (57.5 per 100 cow-years), while no such differences were revealed for individual disorders. There was, however, a significant difference in bulk milk somatic cell counts (BMSCC) between low and high Se herds, their values being 137 000 and 155 000 cells/ml, respectively. This difference was significantly influenced by herd size. Furthermore, a total of 4916 lactations were analyzed from individual health and fertility recordings, including 2 934 first lactations and 1 982 later lactations. The present study revealed a reduced incidence of disease treatment with increased Se concentrations from 0.02 to 0.23 microg Se/g blood. In this regard, there seemed to be an optimum of 0.10 to 0.15 microg Se/g for all types of mastitis treatments summarized, and for treatment of retained placenta. Thus, herd Se concentrations below and above these values was connected with increased probability for sum mastitis and retained placenta, reflecting the effect of the quadratic term of Se. The cow (composite) milk somatic cell count (SCC) was lower in lactations from low Se herds than in high Se herds with a marked SCC increase in the Se concentration interval from 0.11-0.13 microg/g blood. In conclusion, heifers and dry period cows in Norway are low in blood Se content and there seems to be a positive association between increased blood Se concentration pre partum and decreased incidence of mastitis, ovarian cysts and anoestrus/silent oestrus post partum.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16398334 PMCID: PMC1618966 DOI: 10.1186/1751-0147-46-229
Source DB: PubMed Journal: Acta Vet Scand ISSN: 0044-605X Impact factor: 1.695
Blood Se concentration, mean with standard deviation (SD) of herd samples from heifers and dry period cows in different counties of Norway.
| Region | Number of herds | Average herd size, cow-years number | Blood Se, μg Se/g blood ± SD |
| Hedmark | 55 | 26.3 | 0.12 ± 0.05 |
| Oppland | 81 | 19.0 | 0.08 ± 0.03 |
| Rogaland | 96 | 24.3 | 0.10 ± 0.05 |
| Trøndelag | 22 | 16.8 | 0.06 ± 0.03 |
| Total | 254 | 22.4 | 0.09 ± 0.05 |
Parameters related to management, production, feeding, fertility and health given as average for herds with low (<0.06 μg Se/g), medium (0.06–0.11 μg Se/g) and high blood Se concentrations (>0.11 μg Se/g).
| Variable | Low Se herds | Medium Se herds | High Se herds | |
| Number of herds | 60 | 121 | 71 | |
| Se, μg/g blood | 0.04 | 0.08 | 0.16 | <0.001 |
| Cow-years, number | 21.4 | 19.3 | 27.5 | <0.01 |
| Milk yield, kg per cow-year | 6 541 | 6 444 | 6 575 | 0.67 |
| Replacement* | 57.6 | 49.3 | 50.1 | 0.13 |
| Culled cows* | 55.7 | 46.5 | 46.9 | 0.26 |
| Culled cows due to mastitis/SCC* | 11.9 | 8.8 | 10.2 | 0.37 |
| Culled cows due to other diseases* | 1.9 | 1.7 | 2.5 | 0.06 |
| Total number of feeding units milk (FUM) per cow year | 4 912 | 4 795 | 5 019 | 0.20 |
| Concentrate, % of energy consumption | 34.1 | 38.4 | 34.5 | 0.99 |
| Grass silage, % of energy consumption | 37.8 | 36.7 | 37.2 | 0.39 |
| Pasture, % of energy consumption | 14.3 | 13.5 | 11.9 | 0.35 |
| Hay, % of energy consumption | 1.8 | 3.5 | 2.5 | 0.59 |
| NH3 treated straw, % of energy consumption | 1.2 | 1.4 | 2.5 | 0.01 |
| Turnips, % of energy consumption | 0.06 | 0.55 | 0.43 | 0.01 |
| Potatoes, % of energy consumption | 0.32 | 0.55 | 0.39 | 0.52 |
| Brewer's grain, % of energy consumption | 0.32 | 0.40 | 1.22 | 0.04 |
| FS-value | 66 | 71 | 69 | 0.31 |
| Calving interval, days | 378.0 | 377.7 | 374.2 | 0.32 |
| Anoestrus/silent oestrus** | 5.2 | 4.2 | 4.3 | 0.84 |
| Cystic ovaries** | 1.1 | 2.1 | 1.0 | 0.59 |
| Metritis** | 1.7 | 1.9 | 1.5 | 0.83 |
| Abortion** | 0.5 | 0.5 | 0.4 | 0.35 |
| Severe/moderate clinical mastitis** | 20.8 | 20.9 | 19.3 | 0.63 |
| Clinical mastitis** | 31.2 | 33.6 | 28.7 | 0.37 |
| Sub and mild clinical mastitis** | 15.2 | 17.3 | 15.6 | 0.80 |
| All mastitis** | 32.9 | 34.5 | 31.2 | 0.50 |
| BMSCC, 1000 cells pr ml | 137 | 132 | 155 | 0.03 |
| Ketosis** | 6.6 | 6.1 | 4.3 | 0.12 |
| Teat treatments** | 4.8 | 5.1 | 4.5 | 0.49 |
| Retained placenta** | 4.9 | 4.7 | 4.1 | 0.20 |
| All disease treatments** (health and fertility) | 64.8 | 62.0 | 57.5 | 0.09 |
* number per 100 cow-years (CY).
** number of treated cows per 100 cow-years
The results of models with logistic regression for the effect of Se and Se2 presented by the intercept (a), regression coefficient of Se (b1) and the regression coefficient of Se2 (b2) on mastitis and reproductive diseases during specified observational time and stratified into first, older or all lactations.
| Disease Per lactations included | Observation period, parturition ± number of days | a ± SD | b1 ± SD | b2 ± SD |
| All mastitis treatments | ||||
| All | -10 + 30 | -1.52 ± 0.25 *** | -12.1 ± 5.7* | 43.6 ± 28.4 P=.12 |
| 1st | -10 + 30 | -1.68 ± 0.31*** | -9.83 ± 6.83 P=.15 | 38.3 ± 33.1 P=.25 |
| >1st | -10 + 30 | -1.33 ± 0.31*** | -15.4 ± 7.1* | 50.3 ± 34.5 P=.14 |
| Treatments of severe/moderate clinical mastitis | ||||
| All | -10 to + 30 | -2.37 ± 0.14*** | -2.36 ± 1.21* | |
| 1st | -10 to + 30 | -2.37 ± 0.18*** | -1.67 ± 1.56 P=.28 | |
| >1st | -10 to + 30 | -2.35 ± 0.19*** | -3.65 ± 1.74* | |
| Treatments of severe/moderate clinical mastitis | ||||
| All | -10 to +6 | -2.71 ± 0.16*** | -3.14 ± 1.42* | |
| 1st | -10 to +6 | -2.77 ± 0.23*** | -2.61 ± 0.20 P=.18 | |
| >1st | -10 to +6 | -2.63 ± 0.20*** | -4.15 ± 1.87* | |
| SCC (as log), first measurement in lactation (corrected for lactation number and days in milk) | ||||
| All | +6 to +90 | 5.35 ± 0.10*** | 1.49 ± 0.58** | |
| 1st | +6 to +90 | 4.65 ± 0.12*** | 2.15 ± 0.64*** | |
| >1st | +6 to +90 | 5.43 ± 0.13*** | 0.85 ± 0.77 ns | |
| SCC (as log), geometric mean of three measurements before 270 day in lactation (corrected for lactation number) | ||||
| All | +6 to +270 | 4.43 ± 0.06*** | 1.50 ± 0.49** | |
| 1st | +6 to +270 | 3.73 ± 0.06*** | 2.06 ± 0.58*** | |
| >1st | +6 to +270 | 4.48 ± 0.08*** | 1.02 ± 0.62P = 0.10 | |
| Retained placenta | ||||
| All | 0 + 5 | -2.92 ± 0.36*** | -10.98 ± 6.74 P=.10 | 51.4 ± 26.7* |
| Cystic ovaries | ||||
| All | 0+150 | -3.65 ± 0.27*** | -7.06 ± 2.77** | |
| Anoestrus/silent oestrus | ||||
| All | 0+150 | -2.89 ± 0.30*** | -8.94 ± 3.34** | |
| All disease treatments | ||||
| All | 0+100 | -1.01 ± 0.096*** | -1.67 ± 0.89 P=.06 | |
*** P < 0.001; ** P < 0.01; * P < 0.05
Figure 1Estimated probabilities of different diseases according to Se concentration, based on results of the models in Table 3.
Figure 2Estimated accumulated incidence risk (IR) of mastitis treatments at three different selenium concentrations and relative risk (RR) comparing selenium concentration <0.06 with > 0.11 μg/g blood throughout lactation from -15 to 305 days in milk. RR 14 days is the average RR for each period of the 14 preceding days in milk.